Lastly, there are some other potential predictors including Cyclooxigenase-2 (COX2) expression for endometrial carcinoma [31], but this is beyond the scope of the study and further research to prove the incremental diagnostic value of COX2 and β-catenin should be done. This evidence concerns the gene PTGS2 and endometrial carcinoma.